$45M additional funding bolsters development of canine longevity drugMarch 25, 2024The latest financing round brings the total funds raised for the first FDA-approved dog lifespan extension drug to $125M
SPONSORED CONTENTThe Case for Year-Round Heartworm Prevention and Affordable OptionsVeterinarians are often more than just clinicians - they’re advisors, educators, and, increasingly, financial counselors. In today’s economy, pet owners may hesitate to invest in year-round prevention due to budget constraints; but, skipping even a few months of heartworm protection can have serious consequences. + Learn More
Canine longevity drug starts clinical trialFebruary 1, 2024A whippet named Boo is the first dog dosed in the study to demonstrate healthy lifespan extension in dogs treated with LOY-002
Canine cancer biomarkers to be exploredJune 23, 2021Determining early indicators of disease and helping dogs lead the longest, healthiest lives possible is the driving force behind Morris Animal Foundation’s latest partnership.
